title: In reply--Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
authors.affiliation: Kaiser Permanente, Pasadena, CA.
authors.forename: T Craig
authors.initials: TC
authors.lastname: Cheetham
authors.affiliation: Kaiser Permanente, Pasadena, CA.
authors.forename: Lina S
authors.initials: LS
authors.lastname: Sy
authors.affiliation: Kaiser Permanente, Pasadena, CA.
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Jacobsen
mesh_terms: D005260:Female; D006562:Herpes Zoster / Q000453:epidemiology*; D053061:Herpes Zoster Vaccine / Q000627:therapeutic use*; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D018570:Risk Assessment / Q000379:methods*; D014611:Vaccination / Q000379:methods*
chemical_list: D053061:Herpes Zoster Vaccine; D007166:Immunosuppressive Agents